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Abstract
Background. Hepatic portal vein gas (HPVG) is a radiological finding normally associated with life-threatening conditions
such as mesenteric ischaemia and necrotising enterocolitis in infants. Its presence has previously been associated with a high
mortality rate. As a result of more sensitive imaging modalities the spectrum of conditions for which portal vein gas is detected
has broadened. We present a patient who developed HPVG as a complication of cryotherapy. The association between portal
vein gas and cryotherapy has not previously been described in well over one thousand patients with hepatic cryotherapy
reported in the literature.
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Case report
A 50-year-old man presented to our unit with a 3-day
history of rigors 2 weeks after cryoablation for recur-
rent colorectal hepatic metastases. Two years
previously, in 2001, he had undergone a right hemi-
colectomy for colorectal carcinoma. In 2002, meta-
static liver disease was treated with a combination of
hepatic resection and cryotherapy for lesions of 1.5, 1.5
and 3 cm in diameter. In addition, a hepatic artery
catheter was inserted. Postoperative intra-arterial
5-fluoro-2-deoxuridinechemotherapywascomplicated
by sclerosing cholangitis, limiting the treatment course
to 2 months and necessitating the change to systemic
chemotherapy. In 2003, computer tomography (CT)
imaging demonstrated a recurrence at one of the
previous cryotherapy sites. Further cryotherapy was
undertaken at open operation together with removal of
the hepatic artery catheter pump as the catheter had
blocked. During this operation a colonic injury was
created while dividing adhesions and was oversewn.
The postoperative course was complicated by fevers
that settled when a right subphrenic collection was
drained.
Three weeks after the operation, the patient
presented to hospital with a short history of rigors and
no other associated symptoms. The physical exam-
ination was unremarkable. The liver biochemistry was
markedly deranged with a mixed picture of hepato-
cellular dysfunction and obstruction. A provisional
diagnosis of biliary sepsis was made, given the history
and a CT scan that demonstrated extensive portal vein
gas (Figure 1). Treatment with broad-spectrum intra-
venous antibiotics was commenced. Ten hours after
the CT scan, the patient developed septic shock for
which he required aggressive fluid resuscitation and
inotropic support in the intensive care unit. The clin-
ical picture improved sharply over the next 24 hours
and serial CT imaging revealed complete resolution of
the gas within 48 hours.
A number of organisms were isolated from blood
cultures taken during the septic episode. These inclu-
ded Enterococcus faecalium, methicillin-resistant
Staphylococcus aureus (MRSA), Saccharomyces
cerevisiae and Streptococcus spp.
Despite the early signs of recovery, the patient
subsequently developed portal vein thrombosis and
MRSA intra-hepatic sepsis. Despite aggressive anti-
biotic therapy and surgical debridement of necrotic
liver, he continued to deteriorate and died from hepatic
failure 2 months after the initial detection of HPVG.
Discussion
Gas in the portal vein was first reported by Wolfe and
Evans in 1955 in infants. Subsequently the condition
was described in adults in 1960 [1,2]. In a literature
review of all reported cases before 1978 (n=64),
Liebman and colleagues demonstrated necrotic bowel
in 72% and a mortality rate of 75% [3]. Since then,
portal vein gas has been associated with a number of
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other diagnoses including cholangitis, cholecystitis,
Crohn’s disease, candida enterocolitis in human
immunodeficiency virus disease, ischaemic bowel
disease and blunt trauma. Iatrogenic causes include
sigmoidoscopy, colonoscopy, endoscopic retrograde
cholangiopancreatography, barium enema, renal
transplants and liver transplants. Despite the increased
diagnoses linked with portal vein gas, it still remains
most commonly associated with necrotic bowel [4].
The relative increase in iatrogenic causes and the
broadening of the clinical settings associated with this
condition require the development of more sensitive
imaging modalities. Both CT and colour Doppler
ultrasound have superior sensitivity for detecting portal
vein gas over plain films [5]. Although portal vein gas
used to be an absolute indication for laparotomy, most
iatrogenic cases have successfully been managed non-
operatively [4].
Two pathogenic mechanisms for portal vein gas have
been described. The first suggests that increased
intraluminal pressure allows gas to enter the mesen-
teric veins directly through a damaged mucosal wall,
while the second proposes that gas-forming micro-
organisms gain entry through a damaged endothelium
into the portal venous system. Either mechanism
would find a favourable environment created with the
triad of factors which are considered to predispose to
portal vein gas: bowel distension, intestinal wall
alteration and sepsis (defined as positive blood culture,
abscess or necrotic bowel) [6]. With the exception of
sepsis, these factors did not appear to play a major role
in the present case. Sepsis was confirmed by positive
blood cultures, but there was no suggestion of bowel
ischaemia. The presumed mechanism of gas formation
in this case is direct micro-organism invasion of the
portal system from a cryotherapy abscess that had
formed at a cryotherapy site that directly abutted
the portal sheath and had become infected from
abdominal contamination associated with the colonic
perforation.
To our knowledge, portal vein gas has not previously
been associated with cryoablation. The association
between portal vein gas and cryotherapy has not been
described previously in well over one thousand patients
undergoing hepatic cryotherapy reported in the litera-
ture [7]. We are aware of the risk of cryo-site abscess
formation with synchronous cryotherapy and bowel
resection. We have previously reported nine patients
undergoing synchronous cryotherapy and bowel
resection of whom two developed a cryo-site abscess
(22%), which is a significantly greater incidence than
the accepted figure of 2% achieved in non-synchronous
operations [8]. Similarly, synchronous bowel resection
and radiofrequency ablation of metastases is also
associated with an increased rate of abscess formation
and hepatic sepsis [9]. Commonsense dictates that
operations that may favour the formation of cryo-site
abscesses close to the portal sheath may also favour the
development of portal vein gas. While in this case we
did not undertake synchronous bowel resection,
contamination could have occurred from the colonic
injury.
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Figure 1. Computer tomography (CT) scan demonstrating
widespread portal vein gas.
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